Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Myriad Genetics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Neo Ivy Capital Renee Yao | 3,488 | $85 | 0.01% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$16.62 | 15,000 | Director | 66,790 | 2020-11-11 | Filing | |
$25.60 | 5,860 | Director | 54,150 | 2019-12-13 | Filing | |
$23.46 | 1,750 | Director | 2,050 | 2019-11-07 | Filing | |
$23.46 | 5,250 | Director | 64,353 | 2019-11-07 | Filing | |
$18.57 | 400 | Director | 42,524 | 2017-02-23 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$22.05 | 3,788 | Director | 32,917 | 2024-06-04 | Filing | |
$22.04 | 3,788 | Director | 36,705 | 2024-06-03 | Filing | |
$25.07 | 75,000 | Officer, Director | 1,066,166 | 2024-05-15 | Filing | |
$25.21 | 95,000 | Officer, Director | 1,141,166 | 2024-05-14 | Filing | |
$25.13 | 57,844 | Officer, Director | 1,236,166 | 2024-05-13 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 14,658,349 | $280,560,800 | 0% | |
2. | 9,954,233 | $190,524,020 | 0% | |
3. | 7,219,706 | $138,185,172 | 0.02% | |
4. | 4,700,631 | $89,970,077 | 0% | |
5. | 3,913,913 | $74,912,295 | 0.37% |